Carregant...

Association between β-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension

BACKGROUND: β-Blocker therapy has been shown to improve survival among patients with ischaemic heart disease (IHD) and congestive heart failure (CHF) and is underused among patients with chronic obstructive pulmonary disease (COPD). Evidence regarding the optimal use of β-blocker therapy during an a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Thorax
Autors principals: Stefan, Mihaela S, Rothberg, Michael B, Priya, Aruna, Pekow, Penelope S, Au, David H, Lindenauer, Peter K
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4454610/
https://ncbi.nlm.nih.gov/pubmed/22941975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thoraxjnl-2012-201945
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!